CIK 0001840233
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Xilio Therapeutics, Inc.
Sign in to watch- Ticker
- XLO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851623397
- Phone
- +1 617-833-1027
- Business address
- 828 WINTER STREET, WALTHAM, MA, 02451
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 42,469 shares at an average $9.66 ($410,161)
- 3 Insider Initial Statement of Ownership
- 4/A Open-market buy 10% owner bought 625,000 shares at $16.00 ($10,000,000)
- 4 Open-market buy 10% owner bought 775,000 shares at $16.00 ($12,400,000)
- 4 Conversion See Remark 1 acquired 218,705 shares (conversion)
- 4 Conversion See Remark 1 acquired 1,881,355 shares (conversion)
- 4 Conversion 10% owner acquired 2,602,264 shares (conversion)
- 4 Conversion 10% owner acquired 1,475,121 shares (conversion)
- 4 Open-market buy 10% owner bought 250,000 shares at $16.00 ($4,000,000)
- 4 Conversion 10% owner acquired 680,825 shares (conversion)
- 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
- 4 Open-market buy 10% owner bought 312,500 shares at $16.00 ($5,000,000)
- 4 Open-market buy 10% owner bought 187,500 shares at $16.00 ($3,000,000)
- 4 Derivatives Options or other derivatives
Page 6 of 8 · 150 filings